pET-NT*-HRV3CP Citations (3)

Originally described in: NT*-HRV3CP: an optimized construct of human rhinovirus 14 3C protease for high-yield expression and fast affinity-tag cleavage.
Abdelkader EH, Otting G J Biotechnol. 2020 Nov 6. pii: S0168-1656(20)30306-0. doi: 10.1016/j.jbiotec.2020.11.005. PubMed Journal

---

Articles Citing pET-NT*-HRV3CP

Articles
CONFORMATIONAL FLEXIBILITY IS A CRITICAL FACTOR IN DESIGNING BROAD-SPECTRUM HUMAN NOROVIRUS PROTEASE INHIBITORS. Pham S, Zhao B, Neetu N, Sankaran B, Patil K, Ramani S, Song Y, Estes MK, Palzkill T, Prasad BVV. bioRxiv [Preprint]. 2024 Sep 19:2024.09.16.613336. doi: 10.1101/2024.09.16.613336. PubMed
Secondary sphere interactions modulate peroxynitrite scavenging by the E2 domain of amyloid precursor protein. Zuercher EC, Poore AT, Prajapat D, Palazzo J, Thomas A, Birthright C, Lawrence J, Chen M, Tian S. Dalton Trans. 2025 Jan 2;54(2):571-581. doi: 10.1039/d4dt02552k. PubMed
Sequence and biochemical analysis of vaccinia virus A32 protein: Implications for in vitro stability and coiled-coil motif mediated regulation of the DNA-dependent ATPase activity. Ramakrishnan U, Aggarwal T, Kondabagil K. PLoS One. 2025 Jan 6;20(1):e0316818. doi: 10.1371/journal.pone.0316818. eCollection 2025. PubMed

If you have published an article using this material, please email us at to have your article added to this page.